D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 65 Citations 11,393 292 World Ranking 6069 National Ranking 2858

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cancer
  • Apoptosis

Viswanathan Natarajan spends much of his time researching Cell biology, Biochemistry, Lung injury, Sphingosine and NADPH oxidase. His Cell biology research incorporates themes from Endothelial stem cell and Endothelium. His biological study spans a wide range of topics, including Hemostasis and Platelet.

His Lung injury study combines topics from a wide range of disciplines, such as Immunology and Vascular permeability. As part of one scientific family, Viswanathan Natarajan deals mainly with the area of Sphingosine, narrowing it down to issues related to the Sphingolipid, and often Ceramide and Sphingosine kinase. His Reactive oxygen species research integrates issues from Molecular biology and Hyperoxia.

His most cited work include:

  • Reactive oxygen species at the crossroads of inflammasome and inflammation. (189 citations)
  • Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells. (168 citations)
  • Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products. (155 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of study are Cell biology, Cancer research, Lung injury, Biochemistry and Lung. His Cell biology research is multidisciplinary, relying on both Endothelial stem cell, Sphingosine-1-phosphate and Endothelium. In Cancer research, Viswanathan Natarajan works on issues like Pulmonary fibrosis, which are connected to Idiopathic pulmonary fibrosis.

His research investigates the link between Lung injury and topics such as Sphingosine that cross with problems in Sphingolipid and Kinase. His study explores the link between Lung and topics such as Inflammation that cross with problems in Asthma. The various areas that Viswanathan Natarajan examines in his Signal transduction study include Lysophosphatidic acid and Protein kinase A.

He most often published in these fields:

  • Cell biology (40.37%)
  • Cancer research (24.07%)
  • Lung injury (20.00%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (24.07%)
  • Lung (15.19%)
  • Cell biology (40.37%)

In recent papers he was focusing on the following fields of study:

Viswanathan Natarajan mainly investigates Cancer research, Lung, Cell biology, Lung injury and Sphingosine kinase 1. His Cancer research study combines topics in areas such as Acyltransferase, Gene knockdown, Mitochondrial DNA, Cystic fibrosis transmembrane conductance regulator and Pulmonary fibrosis. His biological study spans a wide range of topics, including WWOX, Epithelial–mesenchymal transition and Immunology.

His Cell biology research includes themes of Sphingosine-1-phosphate, Thrombin and Alveolar Epithelium. In his study, Lipid signaling, Chromatin remodeling and Sphingosine kinase is strongly linked to Sphingolipid, which falls under the umbrella field of Sphingosine-1-phosphate. He has researched Lung injury in several fields, including Endothelial stem cell, Inflammation and Neonatal stage, Endocrinology.

Between 2017 and 2021, his most popular works were:

  • Airway Epithelial Cell-Derived Colony Stimulating Factor-1 Promotes Allergen Sensitization. (21 citations)
  • Nuclear lipid mediators: Role of nuclear sphingolipids and sphingosine-1-phosphate signaling in epigenetic regulation of inflammation and gene expression. (20 citations)
  • Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1 (17 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Apoptosis
  • Cancer

Viswanathan Natarajan mainly focuses on Cancer research, Lung injury, Sphingosine-1-phosphate, Cell biology and Lung. The various areas that Viswanathan Natarajan examines in his Cancer research study include Apoptosis, Mitochondrial DNA, Idiopathic pulmonary fibrosis, Pulmonary fibrosis and Ubiquitin ligase. His work in Lung injury addresses subjects such as Integrin alpha M, which are connected to disciplines such as Inflammation.

His work deals with themes such as Sphingolipid and Ceramide, which intersect with Sphingosine-1-phosphate. His work investigates the relationship between Ceramide and topics such as Sphingosine kinase that intersect with problems in Signal transduction. Lung is closely attributed to Immunology in his study.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Reactive oxygen species at the crossroads of inflammasome and inflammation.

Anantha Harijith;David L. Ebenezer;Viswanathan Natarajan.
Frontiers in Physiology (2014)

281 Citations

Role of sphingosine-1 phosphate in the enhancement of endothelial barrier integrity by platelet-released products.

Kane L. Schaphorst;Eddie Chiang;Keri N. Jacobs;Ari Zaiman.
American Journal of Physiology-lung Cellular and Molecular Physiology (2003)

236 Citations

Hyperoxia-induced NAD(P)H oxidase activation and regulation by MAP kinases in human lung endothelial cells.

Narasimham L. Parinandi;Michael A. Kleinberg;Peter V. Usatyuk;Rhett J. Cummings.
American Journal of Physiology-lung Cellular and Molecular Physiology (2003)

224 Citations

Role of Nox4 and Nox2 in Hyperoxia-Induced Reactive Oxygen Species Generation and Migration of Human Lung Endothelial Cells

Srikanth Pendyala;Irina A Gorshkova;Peter V. Usatyuk;Donghong He.
Antioxidants & Redox Signaling (2009)

221 Citations

Ethnic Differences and Functional Analysis of MET Mutations in Lung Cancer

Soundararajan Krishnaswamy;Rajani Kanteti;Jonathan S. Duke-Cohan;Sivakumar Loganathan.
Clinical Cancer Research (2009)

204 Citations

NADPH oxidase is required for the Sensory Plasticity of the Carotid body by Chronic Intermittent Hypoxia

Y. J. Peng;J. Nanduri;G. Yuan;N. Wang.
The Journal of Neuroscience (2009)

204 Citations

Basic Fibroblast Growth Factor Stimulates Matrix Metalloproteinase-13 via the Molecular Cross-talk between the Mitogen-activated Protein Kinases and Protein Kinase Cδ Pathways in Human Adult Articular Chondrocytes

Hee Jeong Im;Prasuna Muddasani;Viswanathan Natarajan;Thomas M. Schmid.
Journal of Biological Chemistry (2007)

204 Citations

Role of mitogen-activated protein kinases in 4-hydroxy-2-nonenal-induced actin remodeling and barrier function in endothelial cells.

Peter V. Usatyuk;Viswanathan Natarajan.
Journal of Biological Chemistry (2004)

196 Citations

Redox regulation of 4-hydroxy-2-nonenal-mediated endothelial barrier dysfunction by focal adhesion, adherens, and tight junction proteins.

Peter V. Usatyuk;Narasimham L. Parinandi;Viswanathan Natarajan.
Journal of Biological Chemistry (2006)

185 Citations

Oxidized Phospholipids Reduce Vascular Leak and Inflammation in Rat Model of Acute Lung Injury

Stephanie Nonas;Ian Miller;Kamon Kawkitinarong;Santipongse Chatchavalvanich.
American Journal of Respiratory and Critical Care Medicine (2006)

173 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Viswanathan Natarajan

Joe G.N. Garcia

Joe G.N. Garcia

University of Arizona

Publications: 122

Nigel J. Pyne

Nigel J. Pyne

University of Strathclyde

Publications: 63

Susan Pyne

Susan Pyne

University of Strathclyde

Publications: 61

Andrew J. Morris

Andrew J. Morris

University of Kentucky

Publications: 52

Stuart M. Pitson

Stuart M. Pitson

University of South Australia

Publications: 48

Ravi Salgia

Ravi Salgia

City Of Hope National Medical Center

Publications: 46

Konstantin G. Birukov

Konstantin G. Birukov

University of Chicago

Publications: 43

Nanduri R. Prabhakar

Nanduri R. Prabhakar

University of Chicago

Publications: 38

Hee-Jeong Im

Hee-Jeong Im

University of Illinois at Chicago

Publications: 37

Anna A. Birukova

Anna A. Birukova

University of Maryland, Baltimore

Publications: 35

Lina M. Obeid

Lina M. Obeid

Stony Brook University

Publications: 34

Sarah Spiegel

Sarah Spiegel

Virginia Commonwealth University

Publications: 31

David N. Brindley

David N. Brindley

University of Alberta

Publications: 31

Jerold Chun

Jerold Chun

Discovery Institute

Publications: 27

Ting Wang

Ting Wang

Washington University in St. Louis

Publications: 25

Alexander D. Verin

Alexander D. Verin

Augusta University

Publications: 25

Trending Scientists

Sonia Fahmy

Sonia Fahmy

Purdue University West Lafayette

Zhiwu Li

Zhiwu Li

Macau University of Science and Technology

Satyajit Roy

Satyajit Roy

Indian Institute of Technology Madras

Peter P. Fu

Peter P. Fu

United States Food and Drug Administration

Vito Lippolis

Vito Lippolis

University of Cagliari

Matthew Copel

Matthew Copel

IBM (United States)

Jérôme Goudet

Jérôme Goudet

University of Lausanne

Maria Trojanowska

Maria Trojanowska

Boston University

Alian Wang

Alian Wang

Washington University in St. Louis

Charles T. Garten

Charles T. Garten

Oak Ridge National Laboratory

Timothy R. Oke

Timothy R. Oke

University of British Columbia

Robert A. Montgomery

Robert A. Montgomery

New York University

Ivan F. McMurtry

Ivan F. McMurtry

University of South Alabama

Yi-Long Wu

Yi-Long Wu

Guangdong Provincial People’s Hospital

John T. O'Brien

John T. O'Brien

University of Cambridge

Richard C. Mohs

Richard C. Mohs

Eli Lilly (United States)

Something went wrong. Please try again later.